In November 2003, researchers at Cambridge University announced they had identified a gene associated with an elevated risk of breast and related ovarian cancers. The gene—christened EMSY in honor of a breast-cancer nurse who is the sister of the study's lead author—is particularly significant because it is linked to so-called sporadic cancers. Such cancers do not arise from hereditary mutations of the BRCA1 and BRCA2 genes, in which genes that ordinarily prevent breast and ovarian cancers are altered, often giving rise to multiple cases of cancer within a family as the mutation is passed along. The Cambridge researchers determined that the presence of extra copies of EMSY in an individual may instead switch off a healthy BRCA2 gene
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1017/S0963180104134130
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 71,410
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

The Family Covenant and Genetic Testing.David J. Doukas & Jessica W. Berg - 2001 - American Journal of Bioethics 1 (3):2 – 10.
Genetic Disease, Genetic Testing and the Clinician.Kelly C. Smith - 2001 - Journal of the American Medical Association 285 (1):91.
Autonomy and Freedom of Choice in Prenatal Genetic Diagnosis.Elisabeth Hildt - 2002 - Medicine, Health Care and Philosophy 5 (1):65-72.
Patient Complains of …: How Medicalization Mediates Power and Justice.Alison Reiheld - 2010 - International Journal of Feminist Approaches to Bioethics 3 (1):72-98.


Added to PP index

Total views
19 ( #585,153 of 2,519,862 )

Recent downloads (6 months)
1 ( #406,012 of 2,519,862 )

How can I increase my downloads?


My notes